Literature DB >> 8414836

Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension.

S H Abman1, J P Kinsella, M S Schaffer, R B Wilkening.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8414836

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  19 in total

1.  Noninvasive inhaled nitric oxide does not prevent bronchopulmonary dysplasia in premature newborns.

Authors:  John P Kinsella; Gary R Cutter; Robin H Steinhorn; Leif D Nelin; William F Walsh; Neil N Finer; Steven H Abman
Journal:  J Pediatr       Date:  2014-07-22       Impact factor: 4.406

Review 2.  Inhaled nitric oxide in neonates.

Authors:  N Finer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

3.  Response to inhalative nitric oxide in a severely acidotic preterm newborn with lung hypoplasia.

Authors:  M Wallot; B Wulff; L Hanssler; T Voit
Journal:  Eur J Pediatr       Date:  1996-12       Impact factor: 3.183

4.  Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants.

Authors:  N V Subhedar; S W Ryan; N J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

Review 5.  Controversies in the identification and management of acute pulmonary hypertension in preterm neonates.

Authors:  Regan E Giesinger; Kiran More; Jodie Odame; Amish Jain; Robert P Jankov; Patrick J McNamara
Journal:  Pediatr Res       Date:  2017-10-04       Impact factor: 3.756

6.  Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure.

Authors:  Monika M Gadhia; Gary R Cutter; Steven H Abman; John P Kinsella
Journal:  J Pediatr       Date:  2013-12-31       Impact factor: 4.406

7.  Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn.

Authors:  V Soditt; C Aring; P Groneck
Journal:  Intensive Care Med       Date:  1997-12       Impact factor: 17.440

8.  Persistent fetal circulation.

Authors:  C D'cunha; K Sankaran
Journal:  Paediatr Child Health       Date:  2001-12       Impact factor: 2.253

9.  Inhaled nitric oxide for avoidance of extracorporeal membrane oxygenation in the treatment of severe persistent pulmonary hypertension of the newborn.

Authors:  W Muller; W Kachel; P Lasch; V Varnholt; S A Konig
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

10.  Extracorporeal life support for neonatal respiratory failure. A 20-year experience.

Authors:  C J Shanley; R B Hirschl; R E Schumacher; M C Overbeck; T N Delosh; R A Chapman; A G Coran; R H Bartlett
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.